Deshpande Shyam J, Tsang Hamilton C, Phuong Jim, Hasan Rida, Liu Zhinan, Stansbury Lynn G, Hess John R, Vavilala Monica S
Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, Washington, USA.
Department of Anesthesiology & Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Paediatr Anaesth. 2025 Jan;35(1):57-65. doi: 10.1111/pan.15024. Epub 2024 Oct 22.
Trauma-induced coagulopathy (TIC) is associated with negative outcomes. Pediatric TIC has been described most often in older children. Children undergo normal developmental hemostasis, but it is unknown how this process impacts the risk of TIC across childhood.
To understand variations in coagulation testing and TIC across pediatric age groups.
We evaluated testing patterns of coagulation studies at presentation and over the first 72 h of hospitalization by pediatric age group at a large, Level I trauma center, 2015-2020. The frequency of TIC was determined using published, age-specific reference ranges and controlling for injury severity. We performed subgroup analyses of those with isolated severe traumatic brain injury (TBI) and those who presented directly from the scene of injury.
Data from 2409 pediatric patients were available; 333 patients had isolated severe TBI. Children <1 year were least likely to be tested for TIC at presentation and over the first 72 h, even among the most injured. Fibrinogen testing was uncommon, regardless of injury severity. TIC was common: 22% of patients had TIC at presentation and 35% by 72 h. Greater injury severity was associated with TIC. Children 1-4 and 5-9 years had a higher frequency of TIC at presentation and over 72 h compared to older children in the least injured cohort. We saw no difference in frequency of TIC between age groups in the subset with isolated severe TBI. Using age-specific criteria, patients most often met TIC criteria by INR/PT, followed by platelet count, and least commonly by aPTT. The presence of TIC was associated with in-hospital mortality (OR 4.10, 95% CI 2.06-8.17).
Significant sampling bias exists in clinical data collection among injured children and adolescents. Contrary to previous reports and using age-specific TIC criteria, younger children are not at lower risk of TIC than older children when controlling for injury severity.
创伤性凝血病(TIC)与不良预后相关。小儿TIC最常见于年龄较大的儿童。儿童经历正常的发育性止血过程,但该过程如何影响整个儿童期TIC的风险尚不清楚。
了解不同年龄组小儿凝血检测和TIC的差异。
我们评估了2015 - 2020年在一家大型一级创伤中心就诊时及住院头72小时内按小儿年龄组划分的凝血研究检测模式。使用已发表的、针对特定年龄的参考范围并控制损伤严重程度来确定TIC的发生率。我们对单纯性严重创伤性脑损伤(TBI)患者和直接从受伤现场送来的患者进行了亚组分析。
有2409例小儿患者的数据可用;333例患者有单纯性严重TBI。1岁以下儿童在就诊时及头72小时内接受TIC检测的可能性最小,即使在受伤最严重的儿童中也是如此。无论损伤严重程度如何,纤维蛋白原检测都不常见。TIC很常见:22%的患者在就诊时有TIC,到72小时时为35%。损伤严重程度越高与TIC相关。与受伤最轻队列中的大龄儿童相比,1 - 4岁和5 - 9岁儿童在就诊时及72小时内TIC的发生率更高。在单纯性严重TBI亚组中,我们未发现不同年龄组之间TIC发生率有差异。根据特定年龄标准,患者最常通过国际标准化比值/凝血酶原时间(INR/PT)符合TIC标准,其次是血小板计数,最不常见的是活化部分凝血活酶时间(aPTT)。TIC的存在与院内死亡率相关(比值比4.10,95%置信区间2.06 - 8.17)。
受伤儿童和青少年的临床数据收集存在显著的抽样偏差。与之前的报告相反,使用特定年龄的TIC标准,在控制损伤严重程度时,年幼儿童发生TIC的风险并不低于大龄儿童。